Mitzy Elena Torres Soriano

• Retina Subspecialist
• Retinologist at Centro de la Vision Gordon-Manavella y Clínica Ferroni

This 3 volume set offers a comprehensive compilation which presents detailed information about ophthalmic (retinal, vitreous and macular) diseases. Key features of this set include: - Emphasis on practical features of clinical diagnosis - Concise and didactic presentation of key manifestations of diseases designed for rapid reference and target...

This 3 volume set offers a comprehensive compilation which presents detailed information about ophthalmic (retinal, vitreous and macular) diseases. Key features of this set include: - Emphasis on practical features of clinical diagnosis - Concise and didactic presentation of key manifestations of diseases designed for rapid reference and target...

This 3 volume set offers a comprehensive compilation which presents detailed information about ophthalmic (retinal, vitreous and macular) diseases. Key features of this set include: - Emphasis on practical features of clinical diagnosis - Concise and didactic presentation of key manifestations of diseases designed for rapid reference and target...

We report the use of intravitreal bevacizumab as a new option in the treatment of central serous chorioretinopathy (CSC). Five eyes with retinal pigment epithelium (RPE) leaks secondary to CSC received intravitreal bevacizumab (2.5 mg/0.1 cc), and underwent best corrected visual acuity, fluorescein angiography and optical coherent tomography before...

Ocular angiogenesis is a major cause of disease and permanent blindness. The introduction of anti-vascular endothelial growth factor (anti-VEGF) agents has revolutionized the treatment of retinal vasogenic conditions. These drugs are now commonly employed for the treatment of a group of ocular pathologies, including exudative macular degeneration,...

Purpose: To report an unusual case of postcataract endophthalmitis secondary to Candida parapsilosis. Case Presentation: A 77-year-old female patient was admitted to the emergency ward with reduced visual acuity (VA), and redness and pain in the right eye (RE) with a few hours of evolution. The patient underwent cataract surgery in the right eye 50...

Background: Trigeminal neuralgia is a rare cause of postoperative pain after ophthalmic surgery and has only been described twice in the international literature: one case of pain after vitrectomy with a crystalline lens extraction and another case of an unspecified surgery type. We report three cases of ophthalmic surgery-induced trigeminal neura...

Background: We report the use of intravitreal bevacizumab as an option for the treatment of ch-ronic or recurrent central serous chorioretinopathy (CSC). Methods: Eight eyes with chronic or recurrent CSC received intravitreal bevacizumab (1.25 mg/0.05 cc) and underwent best corrected visual acuity (VA), optical coherent tomography (OCT), fluorescei...

To determine the short-term safety of intravitreal bevacizumab by multifocal electroretinography testing. Thirty-one eyes with choroidal neovascularization, proliferative diabetic retinopathy, and retinal vein occlusion received intravitreal bevacizumab (2.5 mg/0.1 mL). All patients underwent best-corrected visual acuity measurement, retinal fluore...

Purpose: To assess the short-term complications of a single dose of intravitreal bevacizumab in patients with proliferative diabetic retinopathy (PDR). Methods: Retrospective review of 343 patients with PDR who were treated with intravitreal injection of bevacizumab (2.5 mg/0.1 mL). Results: Five patients (1.45%) presented tractional retinal detach...

Introduction: There are few papers regarding electrophysiological findings after intravitreal application of bevacizumab. We sought to determine the safety and toxicity in a short term follow-up as determined by multifocal electroretinogram (mfERG). Methods: 31 eyes with diverse retinal pathology treated with intravitreal bevacizumab (2.5 mg/0.1 cc...

Cone-rod dystrophy belongs to the inherited retinal dystrophies, having different ways of transmission; it has a prevalence of 1 in 40000, ten times less than retinitis pigmentosa. Main symptoms include photophobia, decreased central visual acuity, hemeralopia, dyschromatopsia and, in advanced stages, loss of peripheral vision and night blindness....